D69.49
Other primary thrombocytopenia
Clinical Classification Guidelines
Inclusion Terms
- Megakaryocytic hypoplasia
- Primary thrombocytopenia NOS
Medical Intelligence & Overview
Other primary thrombocytopenia, classified under ICD-10 code D69.49, is a rare blood disorder characterized by a low platelet count that is not caused by other identifiable conditions. Platelets are small cell fragments vital for blood clotting and wound healing. When their numbers drop significantly, it can lead to increased bleeding risk. This condition often involves issues with the production of platelets in the bone marrow, particularly affecting megakaryocytes, the cells responsible for generating platelets. Unlike secondary thrombocytopenia caused by other medical issues or medications, primary thrombocytopenia originates within the bone marrow itself, often without an identifiable external trigger.
Causes & Symptoms
Clinical Causes: Idiopathic factors leading to impaired megakaryocyte development Bone marrow disorders affecting platelet production, such as megakaryocytic hypoplasia Genetic predispositions or inherited conditions affecting hematopoiesis Autoimmune responses where the body mistakenly attacks platelet-producing cells Certain viral infections that may temporarily impact bone marrow function
Key Symptoms: Unusual or easy bruising Frequent nosebleeds Gum bleeding during dental procedures Petechiae, which are tiny purple or red spots on the skin Prolonged bleeding from cuts Heavy menstrual bleeding In rare cases, internal bleeding symptoms that require immediate medical attention
Diagnostic & Treatment
Diagnosis Path: The diagnosis of other primary thrombocytopenia involves a combination of medical history review, physical examination, and laboratory tests. Key steps include: - Complete blood count (CBC) to measure platelet levels - Bone marrow biopsy to assess megakaryocyte numbers and activity, investigating for megakaryocytic hypoplasia or other marrow abnormalities - Blood tests to exclude other causes of thrombocytopenia, such as infections, autoimmune diseases, or side effects of medications - Additional tests to identify any genetic factors or autoimmune markers A thorough evaluation helps distinguish primary thrombocytopenia from secondary causes and other hematological disorders, guiding appropriate management.
Treatment Protocols: Treatment options depend on the severity of symptoms and the underlying pathology but may include: - Observation for mild cases with no significant bleeding symptoms - Corticosteroids to suppress autoimmune activity if present - Immunoglobulin therapy in cases with immune-mediated destruction - Platelet transfusions during severe bleeding episodes or before surgical procedures - Thrombopoietin receptor agonists to stimulate platelet production - Immunosuppressive drugs if autoimmune mechanisms are involved - Bone marrow stimulants and supportive care tailored to individual patient needs In some cases, if the condition persists or worsens, more advanced interventions like splenectomy (surgical removal of the spleen) may be considered. Regular monitoring of platelet levels and bleeding symptoms is essential for managing this condition effectively.
Clinical Advice & FAQs
Billing Guidance
Is D69.49 a billable ICD-10 code?
Yes, D69.49 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D69.49?
Clinical documentation must specify the nature of Other primary thrombocytopenia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference